Navigation Links
Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
Date:9/4/2007

- Preclinical and Phase 1 Data Scheduled for Presentation at 47th ICAAC on

September 18-19, 2007 -

CARLSBAD, Calif., Sept. 4 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Pink Sheets: ARDC) announced today that it has successfully completed Phase 1 single-ascending-dose, multiple-ascending-dose, food-effect, and drug-interaction studies of RDEA806, a novel HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), in healthy volunteers.

The data from these Phase 1 clinical trials, together with select preclinical data, will be discussed in four poster presentations at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), which is being held September 17-20 in Chicago, Illinois. Abstracts can be accessed on the official ICAAC web site at http://www.icaac.org. The poster titles and presentation details are as follows:

-- "The Discovery of RDEA806: A Potent New HIV NNRTI in Phase 1 Clinical

Trials" will be presented during Poster Session 101 (HIV: New Drugs),

Poster Board #299, Abstract #3285, on Tuesday, September 18,

12:15-1:15 PM in Hall D.

-- "RDEA806: A Potent NNRTI with Broad Activity Against Resistant Strains

of HIV-1 and a High Genetic Barrier to Resistance" will be presented

during Poster Session 101 (HIV: New Drugs), Poster Board #300, Abstract

#1662, on Tuesday, September 18, 12:15-1:15 PM in Hall D.

-- "Safety and Pharmacokinetics of Ascending Single Oral Doses of RDEA806,

a Novel HIV NNRTI, in Healthy Volunteers" will be presented during

Poster Session 160 (Antiviral Agents), Poster Board #23, Abstract

#1609, on Wednesday, September 19, 11:15 AM-12:15 PM in Hall D.

-- "RDEA806, a Potent Non-Nucleoside Reverse Transcriptase Inhibitor with

Less Potential for Drug-Drug Interactions" will be presented during


'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Utah , May 22, 2013  Aribex, Inc., ... X-ray system, today introduced a new color option, black ... the U.S. dental and veterinary markets. The popular white ... last month will continue to be available and both ... dealers. (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) ...
(Date:5/22/2013)... May 22, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or ... products, announced today that the Company will present at the ... 2013 at the Le Parker Meridian hotel, 119 W. 56 ... . The presentation is scheduled to begin at 2:15 p.m. ... Heska Heska Corporation (NASDAQ: HSKA - ...
(Date:5/22/2013)... LAGUNA HILLS, Calif. , May 22, 2013 /PRNewswire/ ... is developing a medical device that will help alleviate ... preeclampsia. APT,s targeted apheresis cartridge is expected to be ... a leading cause of maternal and fetal death. ... in the United States . It ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
(Date:5/22/2013)... The surging growth in specialty beds ... marketing claims to compare mattresses often proves a bit ... bed blog , offers shoppers faced with this dilemma ... latest article. , Titled “ Mattress Comparison Overview – ... readers through the basics of innerspring beds as well ...
(Date:5/22/2013)... Prairie, WI (PRWEB) May 23, 2013 ... , introduced a new feature to its website ... from the agency’s client portfolio through an immersive, 360-degree, ... clients and prospective customers the ability to virtually experience ... a developer of medical technologies and services. Users have ...
(Date:5/22/2013)... May 23, 2013 Existing research shows that bicyclists who ... brain injury, but researchers at Boston Children,s Hospital found ... a 20 percent decrease in deaths and injuries for ... vehicle collisions. , The cross-sectional study, conducted by ... MPH, Rebekah C. Mannix, MD, MPH of Boston Children,s ...
(Date:5/22/2013)... Textile Exchange, a non-profit organization ... industry, today released the 2011-12 Farm & Fiber ... production dropped 8% from last year. This drop ... drop in 2010-11. Half of the organic cotton-growing ... Textile Exchange’s seventh, provides unique data, trends and ...
(Date:5/22/2013)... San Francisco, CA (PRWEB) May 22, 2013 ... funerals costing $6,500 or more on average, a funeral concierge ... a funeral, among other benefits. Funeral Financials ... With the average household income in the U.S. ... recession according to Sentier Research, the average funeral costs 12.6% ...
Breaking Medicine News(10 mins):Health News:Mattress Comparison Overview Released by The Sleepy Shopper; Compares Top Types and Brands 2Health News:Catalyst Exhibits Debuts 360 Degree Virtual Tour of St. Jude Medical Trade Show Booth 2Health News:Rate of bicycle-related fatalities significantly lower in states with helmet laws 2Health News:Organic Cotton Sector Shows Signs of Stabilizing, Demonstrating Strength and Commitment of Producer Groups, According to 2011-12 Textile Exchange Farm & Fiber Report 2Health News:Organic Cotton Sector Shows Signs of Stabilizing, Demonstrating Strength and Commitment of Producer Groups, According to 2011-12 Textile Exchange Farm & Fiber Report 3Health News:Organic Cotton Sector Shows Signs of Stabilizing, Demonstrating Strength and Commitment of Producer Groups, According to 2011-12 Textile Exchange Farm & Fiber Report 4Health News:Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge 2Health News:Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge 3
... Calorie-conscious, health-minded,Americans who love to eat out ... in following,through with New Year,s resolutions. HealthyDiningFinder.com, ... at a growing number,of restaurants nationwide. More ... dining establishments currently participate. Site visitors "search",for ...
... Blades, Inc. and its,medical device division IncisionTech announced ... Sons, Inc. The acquisition of Popper, a leading,specialty ... the combined company the leading contract manufacturer of ... Specialty Blades,originally announced its intention to acquire Popper ...
... SAN FRANCISCO, Jan. 7 Hodge / Niederer / ... firm announced,today that Vicky Goldberg has joined as Partner. ... and will focus on the media, entertainment and,consumer sectors., ... President of Worldwide,Recruitment at Warner Bros. Entertainment, Inc. Before ...
... But those who bought from doctors checked their prescriptions, kept ... News) -- While buying contact lenses online may save time ... follow proper eye care, new research shows. , ... trouble down the line, warned the investigators, who found that ...
... The Columbia Center for Childrens Environmental Health ... Health, has received a $10.4 million grant from ... to study environmental contributors to childhood asthma. ... initiative called Disease Investigation through Specialized Clinically-Oriented Ventures ...
... children are able to imagine their future selves as ... find it difficult to recollect past events, let alone ... that the ability of older adults to form imaginary ... memories. , According to the study, episodic memory, which ...
Cached Medicine News:Health News:Online Resource Keeps Restaurant Diners on Track After New Year's Hype Subsides 2Health News:Vicky Goldberg Joins Executive and Board Search Firm Hodge / Niederer / Cariani / Lindsay 2Health News:Eye Care Lacking in Many Who Buy Contact Lenses Online 2Health News:Columbia Center for Children's Environmental Health receives NIEHS grant to study asthma 2Health News:Columbia Center for Children's Environmental Health receives NIEHS grant to study asthma 3Health News:Columbia Center for Children's Environmental Health receives NIEHS grant to study asthma 4
... 2.4mm channel within a 12.1mm insertion tube. ... linear array ultrasound image for improved reliability, ... resolution, and a 7.5 and 5.0mhz transducer ... & pulsed doppler allows for anatomical orientation ...
... range of diagnosis by using the Convex Scanning ... clear image of blood flow by using the ... accessory elevator has been incorporated and the balloon ... for more advanced and accurate techniques. The FG-36UX ...
... ACL 1000 is an affordable solution ... backup analyzer. The test menu includes a ... and APCR-V Leiden. The ACL 1000 also ... efficiency in your lab. Plus, it's backed ...
... takes the automation and versatility of ... the benefit of electrolyte testing. It's ... for the low- to medium-volume laboratory, ... continuous sample loading. The SYNCHRON CX5 ...
Medicine Products: